Skip to main content

Biostax Corp.

IMUNDelisted Feb 20, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001559356

Biostax Corp. was delisted on Feb 20, 2025; its insiders filed their last Form 4 on Feb 22, 2023; no institution reported holding it in 13F filings for Q2 2023; no superinvestor held it.

Holders of 5% or more of IMUN

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Biostax Corp., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Biostax Corp. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

2 Schedule 13D and 13G filings on Biostax Corp., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on IMUN
Filed (ET)FilerFormStakeChangeEvent dateFiling
Dec 15, 2022Salomonsky Henry Louis13DOld format–New–SEC
Jun 7, 2021Griffin Noreen13DOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Biostax Corp. shares.

No Form 144 notices for Biostax Corp. are on file.